Bridgefront Capital’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $348K | Buy |
+10,708
| New | +$348K | 0.09% | 386 |
|
|
2025
Q1 | – | Sell |
-4,244
| Closed | -$347K | – | 795 |
|
|
2024
Q4 | $347K | Buy |
4,244
+172
| +4% | +$14.1K | 0.12% | 315 |
|
|
2024
Q3 | $465K | Buy |
+4,072
| New | +$465K | 0.18% | 196 |
|
|
2024
Q2 | – | Sell |
-6,594
| Closed | -$450K | – | 622 |
|
|
2024
Q1 | $450K | Buy |
6,594
+3,385
| +105% | +$231K | 0.34% | 90 |
|
|
2023
Q4 | $202K | Buy |
+3,209
| New | +$202K | 0.15% | 297 |
|